Evidence Details for Gsk3b
PMID Title Journal Year Abstract
30136700 High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1-42-induced Alzheimer's disease. Neural Regen Res. 2018 Oct;13(10):1833-1841. doi: 10.4103/1673-5374.238620. 2018 Oct Acupuncture has been shown to ameliorate cognitive impairment of Alzheimer's disease. Acupoints and stimulation frequency influence the therapeutic effect of electroacupuncture. Rat models of Alzheimer's disease were established by injecting amyloid beta 1-42 (Abeta(1-42)) into the bilateral lateral ventricles. Electroacupuncture at 2, 30, and 50 Hz was carried out at Baihui (GV20; 15 degrees obliquely to a depth of 2 mm) and Shenshu (BL23; perpendicularly to 4-6 mm depth), once a day for 20 minutes (each), for 15 days, taking a break every 7 days. The Morris water maze test was conducted to assess the learning and memory. The expression levels of glycogen synthase kinase-3beta (GSK-3beta), pSer9-GSK-3beta, pTyr216-GSK-3beta, amyloid precursor protein and Abeta(1-40) in the hippocampus were determined by western blot assay. Results demonstrated that electroacupuncture treatment at different frequencies markedly improved learning and memory ability, increased synaptic curvatures, decreased the width of synaptic clefts, thickened postsynaptic densities, and downregulated the expression of GSK-3beta, amyloid precursor protein, and Abeta(1-40). pSer9-GSK-3beta expression markedly decreased, while pTyr216-GSK-3beta expression increased. High-frequency (50 Hz) electroacupuncture was more effective than low (2 Hz) or medium-frequency (30 Hz) electroacupuncture. In conclusion, electroacupuncture treatment exerts a protective effect against Abeta(1-42)-induced learning and memory deficits and synapse-ultrastructure impairment via inhibition of GSK-3beta activity. Moreover, high-frequency electroacupuncture was the most effective therapy."

Evidence Sentence: The expression levels of glycogen synthase kinase-3beta (GSK-3beta), pSer9-GSK-3beta, pTyr216-GSK-3beta, amyloid precursor protein and Abeta1-40 in the hippocampus were determined by western blot assay.
Evidence Sentence: Results demonstrated that electroacupuncture treatment at different frequencies markedly improved learning and memory ability, increased synaptic curvatures, decreased the width of synaptic clefts, thickened postsynaptic densities, and downregulated the expression of GSK-3beta, amyloid precursor protein, and Abeta1-40.
Evidence Sentence: pSer9-GSK-3beta expression markedly decreased, while pTyr216-GSK-3beta expression increased.
Evidence Sentence: In conclusion, electroacupuncture treatment exerts a protective effect against Abeta1-42-induced learning and memory deficits and synapse-ultrastructure impairment via inhibition of GSK-3beta activity.
Evidence Sentence: Effects of EA on hippocampal GSK-3beta, p-GSK-3beta (Ser9), p-GSK-3beta (Tyr216), and APP expression in AD rats
Evidence Sentence: Compared with the control and sham-operation groups, the model group exhibited significantly higher levels of GSK-3beta, p-GSK-3beta (Tyr216), and APP, and significantly lower amounts of p-GSK-3beta (Ser9) (all P < 0.01).
Evidence Sentence: EA treatment significantly reduced total GSK-3beta, p-GSK-3beta (Tyr216), and APP levels and increased p-GSK-3beta (Ser9) level (all P < 0.01 vs.